Key facts
- Acorn Bioventures is a venture capital firm based in New York, New York with 1 tracked portfolio company.
- Notable positions include Neuron23.
- Acorn Bioventures has 2 funds on record, raising $199.5M across the 1 that report a size.
- The team roster lists 4 people.
About Acorn Bioventures
Founded in 2017, Acorn Bioventures is a venture capital investment firm based in New York, New York. The firm seeks to invest in companies operating in the biotechnology, pharmaceutical, medical technology, and medicine sectors.
Registered with the SEC
Form ADV · 2026-03 · CRD 304164- Regulatory AUM
- —
- Private fund assets
- $355.3M
- Private funds
- 2 · 2 venture
- Staff
- 5
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as ACORN CAPITAL ADVISORS, LLC).
Free account
See the whole book
- ·Watchlist + alerts for Acorn Bioventures's activity
Create free account
No card required
Portfolio, priced
1 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Neuron23 | — | $271.5M | — |
Funds
2 recorded- ACORN BIOVENTURES 2, L.P.2021—
- ACORN BIOVENTURES, L.P.2019$199.5M
$199.5M raised across the 1 fund that report a size
Team
4 people on record — 4 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Acorn Bioventures invest in?
- Acorn Bioventures has 1 recorded portfolio companies, including Neuron23.
- What is Acorn Bioventures's AUM?
- Acorn Bioventures manages approximately $199.5M in assets.